Paper II
2024 June (Supplementary) (2019 Scheme) · 100 marks · 180 min

Question

Treatment of Chloroquine resistant falciparum malaria

Q114 marksShort Answers

Answer

  • Uncomplicated: full oral course of an Artemisinin-based Combination Therapy (ACT), e.g. Artemether + Lumefantrine — the artemisinin component rapidly reduces parasite biomass, the longer-acting partner clears remaining parasites.
  • Severe/complicated: IV artesunate — current first-line, having replaced IV quinine after trial evidence of significant mortality reduction. IV quinine remains second-line where artesunate is unavailable, given by controlled infusion (never rapid push, given cardiotoxicity risk).
  • Supportive care: careful fluid management (avoiding pulmonary edema), glucose monitoring/correction, and management of complications (renal replacement for AKI, ventilatory support for ARDS) as they arise.
  • Once the patient tolerates oral therapy and the acute severe episode resolves, treatment is completed with a full oral ACT course.

Other Years Asked


Revise MBBS
Preview